Table 4.
Cost saving and cost avoidance classified by drug classes (Study group)
| Drug classes | No. of Interventions n = 127 (%) | Cost Saving (USD) | Cost Avoidance (USD) | Total cost Saved and avoided (USD) |
|---|---|---|---|---|
| Antiinfectives | 51 (40.16) | -1,750.89 | -207.72 | -1,958.61 |
| Cardiovascular drugs | 18 (14.17) | 0.55 | -19.08 | -18.53 |
| Electrolytes, trace elements, and Fluid | 15 (11.81) | 2.09 | -17.49 | -15.40 |
| Anticoagulants | 14 (11.02) | -102.69 | -29.67 | -132.36 |
| Psychoactive and CNS agents | 6 (4.72) | 0.00 | -6.36 | -6.36 |
| Gastrointestinal drugs | 5 (3.94) | 1.82 | -1.06 | 0.77 |
| Antidiabetic agents, Insulin | 2 (1.57) | 0.00 | -5.83 | -5.83 |
| Antiasthmatic agents | 2 (1.57) | 0.00 | 0.00 | 0.00 |
| Analgesics | 1 (0.79) | 0.00 | 0.00 | 0.00 |
| Others* | 13 (10.24) | -122.31 | -7.42 | -129.73 |
| Total | 127 (100) | -1,971.43 | -294.62 | -2,266.05 |
- indicated decrease cost of drug therapy
*
Others drug or cannot classified into drug class e.g. TPN/Enteral intervention